Leiden spin-out Mimetas secures investment from Dutch venture capitalists.
Mimetas, a biotech spin-out of Leiden University, has raised $5.2m in a series A round led by Zeeuws Investerings Fonds (Zif) and Participatiemaatschapij Oost Nederland (Ppm Oost). Unnamed regional and national investors also joined.
Mimetas is developing organs-on-a-chip, using 3D disease and tissue modelling technology. It already has a range of models around a range of diseases and toxicology in its pipeline, at varying degrees of validation, and plans to expand that pipeline with the fresh funding.
Ppm Oost manages…
